| Name | Recombinant Human BMP-4 |
| Purity | Greater than 95% as determined by reducing SDS-PAGE |
| Endotoxin level | <0.01 EU/µg as determined by LAL test. |
| Construction | Recombinant Human Bone morphogenetic protein 4 is produced by our E.coli expression system and the target gene encoding Ser293-Arg408. |
| Accession # | P12644 |
| Host | E.coli |
| Species | Human |
| Predicted Molecular Mass | 13.3 KDa |
| Buffer | Supplied as a 0.2 μm filtered solution of 4mM HCl. |
| Form | Liquid |
| Shipping | The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| Stability&Storage | Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
Alternative Names
Bone morphogenetic protein 4; BMP-4; BMP4; BMP2B; DVR4
Background
Bone morphogenic protein-4 (BMP-4) is one of nine structurally related BMPs belonging to the transforming growth factor-beta (TGF-beta) superfamily of secreted proteins. Mature BMP-4 is a dimer that binds to a multimeric transmembrane receptor with serine/threonine kinase activity. BMP-4 has important roles as a signalling molecule in embryonic tissues, including the developing central and peripheral nervous system, musculature and skeleton. BMP-4 as well as its receptors and their signal transduction pathways play a crucial role in the control of the differentiation and proliferation of the different cell types that constitute the anterior pituitary.
Note
For Research Use Only , Not for Diagnostic Use.